Iza Pharmaceuticals Private Limited - Board Members
Founded in 2022 and headquartered in Kerala, India.
2022 Kozhikode, Kerala (India) Active
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Cheriyeri Peediyakkal Kunhimohamed Appointed as Managing Director since January 2022 | Managing Director | 31-Jan-2022 | Current |
Fidha Fathima Appointed as Director since July 2024 | Director | 08-Jul-2024 | Current |
Mohammed Shaz Appointed as Director since January 2024 | Director | 25-Jan-2024 | Current |
Nidha Cheriyeri Peediakkal Appointed as Director since January 2024 | Director | 25-Jan-2024 | Current |
Rajan Appointed as Director since January 2024 | Director | 25-Jan-2024 | Current |
Sheeba Appointed as Director since January 2024 | Director | 25-Jan-2024 | Current |
Shiji Chembakote Appointed as Director since January 2024 | Director | 25-Jan-2024 | Current |
Wasim Mohamed Appointed as Director since July 2024 | Director | 08-Jul-2024 | Current |
Premium access Complete director detailsUnlock the complete director and KMP records available for Iza Pharmaceuticals Private Limited.
Verified entity values are shown only after access is granted. | |||
People Timeline
Explore the timeline of key personnel in Iza Pharmaceuticals Private Limited's leadership journey.
Loading...
Frequently Asked Questions
You can contact Iza Pharmaceuticals Private Limited through their registered address at Door No. 27/421-A, Nethaji Link Road,, Arayidathupalam, Parayanchery,, Kozhikode Kerala, 673004, India, or via their website if available. Social media links are also provided where applicable.
The current directors of Iza Pharmaceuticals Private Limited are listed above in the "Current Directors & Signatories" section. You can view their names, designations, and appointment dates.
- Rajan
- Sheeba
- Shiji Chembakote
- Nidha Cheriyeri Peediakkal
- Mohammed Shaz
- FIDHA FATHIMA
- CHERIYERI PEEDIYAKKAL KUNHIMOHAMED
- WASIM MOHAMED
Past director details are available under the "Past Directors & Signatories" tab. You may need to upgrade your subscription to view detailed information.